← Back to Analyst Consensus 
ATRC Buy
AtriCure, Inc.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 1 downgrades / 2 reiterations from 3 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Oct 12, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Oct 2, 2026 | Freedom Capital Markets | downgrade | Buy → Hold | — | 43% |
| Sep 2, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Aug 27, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 24, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 28, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Feb 18, 2026 | Canaccord Genuity | maintain | Buy → Buy | $53 | 48% |
| Feb 18, 2026 | UBS | maintain | Buy → Buy | $55 | 54% |
| Feb 18, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $52 | 47% |
| Feb 18, 2026 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Feb 18, 2026 | BTIG | reiterate | Buy → Buy | $54 | 52% |
| Feb 12, 2026 | Needham | reiterate | Buy → Buy | $45 | 50% |
| Dec 16, 2025 | JP Morgan | maintain | Overweight → Overweight | $48 | 54% |
| Oct 30, 2025 | Canaccord Genuity | maintain | Buy → Buy | $64 | 48% |
| Jul 30, 2025 | Needham | maintain | Buy → Buy | $45 | 50% |
| Apr 30, 2025 | BTIG | maintain | Buy → Buy | $52 | 52% |
| Apr 30, 2025 | UBS | maintain | Buy → Buy | $58 | 54% |
| Apr 30, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $60 | 53% |
| Apr 30, 2025 | Needham | maintain | Buy → Buy | $44 | 50% |
| Apr 2, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $60 | 49% |
| Mar 28, 2025 | Canaccord Genuity | maintain | Buy → Buy | $52 | 48% |
| Mar 27, 2025 | BTIG | maintain | Buy → Buy | $58 | 52% |
| Mar 27, 2025 | JP Morgan | maintain | Overweight → Overweight | $46 | 54% |
| Mar 27, 2025 | Needham | reiterate | Buy → Buy | $51 | 50% |
| Mar 21, 2025 | Needham | reiterate | Buy → Buy | $51 | 50% |
| Feb 13, 2025 | BTIG | maintain | Buy → Buy | $57 | 52% |
| Feb 13, 2025 | Oppenheimer | maintain | Outperform → Outperform | $45 | 52% |
| Feb 13, 2025 | Piper Sandler | maintain | Overweight → Overweight | $50 | 54% |
| Feb 13, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $60 | 53% |
| Feb 13, 2025 | Stifel | maintain | Buy → Buy | $48 | 53% |
| Feb 13, 2025 | Needham | reiterate | Buy → Buy | $51 | 50% |
| Feb 13, 2025 | Canaccord Genuity | maintain | Buy → Buy | $66 | 48% |
| Feb 11, 2025 | JP Morgan | maintain | Overweight → Overweight | $51 | 54% |
| Feb 10, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $60 | 53% |
| Jan 22, 2025 | Needham | maintain | Buy → Buy | $51 | 50% |
| Jan 13, 2025 | Needham | reiterate | Buy → Buy | $40 | 50% |
| Dec 9, 2024 | Canaccord Genuity | maintain | Buy → Buy | $61 | 48% |
| Oct 30, 2024 | Canaccord Genuity | maintain | Buy → Buy | $53 | 48% |
| Oct 30, 2024 | Oppenheimer | maintain | Outperform → Outperform | $36 | 52% |
| Oct 30, 2024 | JP Morgan | maintain | Overweight → Overweight | $40 | 54% |
| Oct 30, 2024 | UBS | maintain | Buy → Buy | $40 | 54% |
| Oct 30, 2024 | Needham | maintain | Buy → Buy | $40 | 50% |
| Jul 31, 2024 | BTIG | maintain | Buy → Buy | $53 | 52% |
| Jul 31, 2024 | JP Morgan | maintain | Overweight → Overweight | $30 | 54% |
| Jul 31, 2024 | Stifel | maintain | Buy → Buy | $26 | 53% |
| Jul 31, 2024 | Needham | maintain | Buy → Buy | $34 | 50% |
| Jul 31, 2024 | Piper Sandler | maintain | Overweight → Overweight | $40 | 54% |
| Jul 8, 2024 | Needham | reiterate | Buy → Buy | $40 | 50% |
Price Target Trend
Jun 2, 2026 Latest: $57.56 Oct 25, 2026
EPS Estimates
0y $0.28
Lo: $0.25 Hi: $0.31
9 analysts 0q $0.01
Lo: $-0.03 Hi: $0.05
9 analysts +1y $0.43
Lo: $0.21 Hi: $0.64
9 analysts ▲1
+1q $0.09
Lo: $0.04 Hi: $0.13
9 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days